Incyte (INCY) Q2 Revenue Tops Views
Get Alerts INCY Hot Sheet
Price: $101.92 +3.77%
Financial Fact:
Income (loss) before income taxes: 38.3M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Income (loss) before income taxes: 38.3M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q2 EPS of $0.26, $0.09 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $521.52 million versus the consensus estimate of $473.78 million.
2018 Financial Guidance
The Company has updated its full year 2018 financial guidance, as detailed below.
| Current | Previous | |||||||
| GAAP and Non-GAAP Jakafi net product revenues | $1,350 - $1,400 million | Unchanged | ||||||
| GAAP and Non-GAAP Iclusig net product revenues | $80 - $85 million | Unchanged | ||||||
| GAAP Cost of product revenues | $85 - $95 million | Unchanged | ||||||
| Non-GAAP Cost of product revenues(1) | $64 - $74 million | Unchanged | ||||||
| GAAP Research and development expenses | $1,150 - $1,250 million | Unchanged | ||||||
| Non-GAAP Research and development expenses(2) | $1,008 - $1,103 million | $1,013 - $1,108 million | ||||||
| GAAP Selling, general and administrative expenses | $390 - $410 million | Unchanged | ||||||
| Non-GAAP Selling, general and administrative expenses(3) | $340 - $355 million | Unchanged | ||||||
| GAAP Change in fair value of acquisition-related contingent consideration | $30 million | Unchanged | ||||||
| Non-GAAP Change in fair value of acquisition-related contingent consideration(4) | $0 million | Unchanged |
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules
- Ennis (EBF) Reports In-Line Q1 EPS
- Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share